BacT ALERT FA/FN Plus Culture Services
ID: FA282325Q0029Type: Special Notice
Overview

Buyer

DEPT OF DEFENSE

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/a4405be71205479483ed9ce9d4cd2f99/view
Timeline
  1. 1
    Posted Apr 2, 2025, 12:00 AM UTC
  2. 2
    Updated Apr 2, 2025, 12:00 AM UTC
  3. 3
    Due Apr 14, 2025, 2:00 PM UTC
Description

The Department of Defense, through the Air Force Test Center at Eglin Air Force Base, intends to award a sole-source, firm-fixed-price contract to Biomerieux for the provision of reagents necessary for BacT/ALERT culture services. The procurement includes two specific items: CLIN 0001 for BacT Alert FA Plus and CLIN 0002 for BacT Alert FN Plus, each requiring quantities of 12, with a base year and four option years. These reagents are critical for in-vitro diagnostic applications, supporting essential functions in medical testing and analysis. Interested parties are encouraged to submit written responses by 9:00 am CDT on April 14, 2025, to assess the potential for competitive procurement, with inquiries directed to Christina A. Blair at christina.blair.3@us.af.mil.

Point(s) of Contact
Christina A. Blair
christina.blair.3@us.af.mil
Files
Title
Posted
NOCA-BacT ALERT (signed).pdf
Apr 2, 2025, 5:06 PM UTC
The Air Force Test Center at Eglin Air Force Base intends to award a sole-source, firm-fixed-price contract to Biomerieux for the provision of reagents essential for BacT/ALERT culture services. The proposed solicitation number is FA282325Q0029. The contract includes two items: CLIN 0001 for BacT Alert FA Plus (quantities of 12) and CLIN 0002 for BacT Alert FN Plus (also quantities of 12), each with a base year and four option years. The sole-source acquisition is justified under 41 USC 1901, per FAR 13.106-1(b)(1), with a singular supplier being identified. The NAICS code relevant for this acquisition is 325413, with a size standard of 1,250 employees. This notice is not a request for proposals or quotations, and the government encourages written responses to assess the potential for competitive procurement. The deadline for responses is 14 April 2025, and inquiries should be directed to the contracting officer, Ashley Blair, via email.
SSJ BacT Alert_Redacted.pdf
Apr 2, 2025, 5:06 PM UTC
Lifecycle
Title
Type
BacT ALERT FA/FN Plus Culture Services
Currently viewing
Special Notice
Similar Opportunities
Cost Per Test (CPT): Blood Bank Reagent Testing Supplies for Transfusion Services
Buyer not available
The Department of Defense, specifically the Department of the Army, is soliciting proposals for the provision of Blood Bank Reagent Testing Supplies for the Bayne Jones Army Community Hospital located in Fort Johnson, Louisiana. The procurement aims to secure comprehensive support, including the delivery of standardized testing supplies, maintenance of an integrated automated blood bank analyzer system, and adherence to regulatory compliance, particularly FDA standards. These supplies and services are critical for ensuring the operational efficiency and safety of transfusion services within the hospital. Interested vendors should contact Kevin Vijayan at kevin.vijayan.civ@health.mil or 210-538-4861, or Albert Lee at albert.a.lee.civ@health.mil for further details regarding the solicitation, which is expected to cover the contract period from 2025 to 2030.
Notice of Intent to Sole Source-Hematology Analyzer Supplies
Buyer not available
The Department of Defense, specifically the 341st Medical Group at Malmstrom Air Force Base, intends to award a sole-source contract to SYSMEX AMERICA, INC for the procurement of hematology analyzer supplies. This requirement is critical to ensure compatibility with the existing hematology analyzer equipment, as SYSMEX is the sole manufacturer and does not distribute its products through third parties. The contract will encompass the provision of materials, equipment, and qualified personnel for hematology testing, including 24/7 service coverage, preventive maintenance, and timely shipment of reagents, with a focus on maintaining a 99% operational uptime. Interested parties may submit proposals demonstrating the benefits of competition by May 9, 2025, at 6 PM MST, directed to Contract Administrator Elizabeth Basu at elizabeth.basu@us.af.mil.
CDC DFWED NARST Sensititre Supplies
Buyer not available
The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
COVID-19, Influenza A/B, Seasonal Influenza A subtyping, Influenza A/H5 and Influenza A/H7 Extraction Reagents
Buyer not available
The Department of Defense, through the Naval Medical Research Center (NMRC), intends to award a sole-source contract to Roche Diagnostics Corporation for the procurement of essential supplies required for COVID-19 and various influenza detection assays. This contract encompasses the purchase of reagents for 1,000 extraction reactions every two months over a total of six shipments, amounting to 6,000 reactions, with a total funding of $52,920 allocated from Navy Fiscal Year 2025 funds. The unique qualifications of Roche Diagnostics necessitate this sole-source acquisition, as their products are the only ones meeting the required diagnostic grade quality, thereby excluding competitive bidding under applicable regulations. Interested parties may contact Shamai Carter at shamai.m.carter.civ@health.mil or Deborah Sharpe at deborah.m.sharpe2.civ@health.mil for further information.
Molecular Diagnostics Analyzer and Reagents for detection of the Antibodies and Pathogens
Buyer not available
The Department of Defense, specifically the Department of the Army, is seeking sources for a contract to provide a Molecular Diagnostics Analyzer and Reagents for the detection of antibodies and pathogens, including Herpes simplex virus (HSV 1 and 2), congenital cytomegalovirus (CMV), Candida auris, and Varicella Zoster Virus (VZV). The procurement aims to enhance diagnostic capabilities at the Joint Base Lewis McChord Health Contracting Branch by acquiring FDA-approved systems that can perform qualitative nucleic acid amplification testing (NAAT) with rapid results and minimal downtime. This initiative is critical for improving patient care and operational efficiency in public health laboratories. Interested parties are encouraged to submit their capabilities statements and relevant information to Cindy Means at cindy.j.means.civ@health.mil by the specified deadline, as this sources sought notice is for market research purposes and does not constitute a formal solicitation.
Urinalysis Reagents and Consumables w/Leased Analyzer for Fort Sill, OKklahoma
Buyer not available
The Department of Defense is preparing to issue a solicitation for a firm fixed-price contract to supply Urinalysis Reagents and Consumables, along with a leased analyzer, for the Reynolds Army Health Clinic located in Fort Sill, Oklahoma. This procurement is structured on a cost per reportable result basis, emphasizing the importance of timely and adequate delivery of supplies to meet the healthcare needs of the clinic. The goods and services sought are critical for conducting urinalysis, which plays a vital role in patient diagnostics and healthcare management. Interested vendors should note that the solicitation is anticipated to be released around April 28, 2025, and can contact MEDCOM at karan.e.quiles.civ@health.mil or by phone at 254-288-8000 for further information.
6640--FY 25 Short Term Emergency Contract Molecular Random Access Analyzer
Buyer not available
The Department of Veterans Affairs intends to award a sole-source contract to Cepheid for a Short Term Emergency procurement of a Molecular Random Access Analyzer, specifically the Cepheid GeneXpert Infinity Reagents and Consumables. This procurement is conducted under FAR 13.5 Simplified Procedures for Certain Commercial Items, emphasizing the need for efficient acquisition of critical laboratory equipment. The selected vendor must demonstrate technical capability to meet the government's requirements, with responses due by January 17, 2025, at 2:00 PM Eastern Time. Interested parties should submit their technical packages to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov, noting that the government will not compensate for the information provided.
Notice of Intent to Sole Source Cost Per Reportable Testing and Lease of MicroScan WalkAway for Naval Medical Center Portsmouth
Buyer not available
The Department of Defense, through the Defense Health Agency, intends to award a sole source Firm-Fixed-Price contract to Beckman Coulter, INC. for the provision of a Cost Per Reportable MicroScan WalkAway system, which includes equipment lease, consumables, and maintenance support. This procurement is critical as the MicroScan WalkAway system is already validated and in use at the Naval Medical Center Portsmouth, ensuring continuity in laboratory operations and avoiding substantial duplication of costs estimated at approximately $300,000 if a new vendor were to be selected. The total estimated value of the contract is $550,348, with a performance period starting from June 1, 2025, to May 31, 2026, and the Government is seeking responses that demonstrate the advantages of competition. Interested parties can direct inquiries to Contract Specialist Lisa Wilk at lisa.c.wilk.civ@health.mil, and should reference "Notice of Intent Question Submission 12215615" in their correspondence.
Chemistry Analyzers - Eglin, AFB Florida
Buyer not available
The Defense Health Agency (DHA) is conducting market research to identify potential sources for providing Chemistry Analyzers at Eglin Air Force Base, Florida. The requirement includes delivering integrated chemistry and immune-chemistry platforms that comply with military standards, perform a specified range of tests, and ensure robust software capabilities, including interfaces with the DHA MHS GENESIS electronic health record system. This procurement is crucial for enhancing medical testing capabilities within the Department of Defense while adhering to regulatory standards, including HIPAA for the protection of health information. Interested parties must submit their responses to the Request for Information (RFI) by 12:00 P.M. Central Time on May 1, 2025, and can direct inquiries to Robby Brinkmann at robert.t.brinkmann.civ@health.mil or Marcus Mattingly at marcus.h.mattingly.civ@health.mil.
Laboratory Reagents
Buyer not available
The Department of Defense, specifically the Naval Medical Research Unit South, is seeking capable vendors to provide laboratory reagents for surveillance and research of tropical infectious diseases in the USSOUTHCOM Area of Responsibility (AOR) based in Lima, Peru. The procurement aims to fulfill a critical requirement for laboratory materials essential for ongoing research efforts, with the intent to award a sole source contract to Belomed S.R.L. if no other capable sources are identified. Interested vendors must submit a capability statement, including management and technical data, by 12:00 PM Local Time on April 29, 2025, via email to Genaro Vasquez at genaro.m.vasquez.ln@health.mil, using the subject line "PAR250014." The contracting office is located at 3230 Lima Pl, Washington DC, 20521.